1/12
01:38 pm
xgn
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
Low
Report
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story [Yahoo! Finance]
1/11
03:18 pm
xgn
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]
Medium
Report
Exagen Inc. Announces Select Preliminary 2025 Financial Results [Yahoo! Finance]
1/11
03:00 pm
xgn
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Medium
Report
Exagen Inc. Announces Select Preliminary 2025 Financial Results
12/22
02:32 am
xgn
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades [Yahoo! Finance]
Medium
Report
How the Narrative Surrounding Exagen Is Evolving After New Guidance and Price Target Upgrades [Yahoo! Finance]
11/11
09:11 am
xgn
Exagen Inc. to Participate in Fourth Quarter Investor Conferences [Yahoo! Finance]
Medium
Report
Exagen Inc. to Participate in Fourth Quarter Investor Conferences [Yahoo! Finance]
11/11
09:00 am
xgn
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Medium
Report
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
11/10
08:03 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $13.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $13.00 to $15.00. They now have a "buy" rating on the stock.
11/7
02:43 am
xgn
How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals [Yahoo! Finance]
Medium
Report
How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals [Yahoo! Finance]
11/5
10:03 am
xgn
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley.
Low
Report
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley.
11/4
07:50 pm
xgn
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding [Yahoo! Finance]
Medium
Report
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding [Yahoo! Finance]
11/4
08:00 am
xgn
Exagen Inc. Reports Strong Q3 2025 Results
Medium
Report
Exagen Inc. Reports Strong Q3 2025 Results
10/27
08:06 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $11.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $11.00 to $15.00. They now have a "buy" rating on the stock.
10/23
09:15 am
xgn
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
Low
Report
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
10/22
08:34 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $11.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $11.00 to $13.00. They now have a "buy" rating on the stock.
10/21
05:05 pm
xgn
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 [Yahoo! Finance]
Low
Report
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 [Yahoo! Finance]
10/21
04:05 pm
xgn
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
Low
Report
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025